Quick Answer
MUSTANG BIO, INC. reported Diluted EPS of $0.39 per share (loss) for fiscal year 2025.
MUSTANG BIO, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.39 | +99.0% |
| 2024 | -$38.57 | +87.1% |
| 2023 | -$299.95 | -2872.7% |
| 2022 | -$10.09 | -1227.6% |
| 2021 | -$0.76 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.07 | +96.4% | +63.2% |
| June 30, 2025 | -$0.19 | +99.0% | -280.0% |
| March 31, 2025 | -$0.05 | +99.8% | +97.4% |
| September 30, 2024 | -$1.96 | -59.3% | +89.3% |
| June 30, 2024 | -$18.36 | -818.0% | +26.0% |
| March 31, 2024 | -$24.81 | -1104.4% | -1917.1% |
| September 30, 2023 | -$1.23 | +49.2% | +38.5% |
| June 30, 2023 | -$2.00 | +20.0% | +2.9% |
- MUSTANG BIO, INC. showed an increase of +99.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, MUSTANG BIO, INC.’s diluted eps has grown by 48.7% (from $0.76 per share (loss) to $0.39 per share (loss)).
- The most recent figure is from MUSTANG BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: